Statements (87)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:associated_with |
gptkb:smallpox
zoonotic diseases |
gptkbp:caused_by |
gptkb:monkeypox_virus
|
gptkbp:clinical_trial |
respiratory symptoms
gastrointestinal symptoms cutaneous lesions |
gptkbp:community_health |
gptkb:quarantine_measures
surveillance travel advisories contact tracing vaccination campaigns quarantine community awareness campaigns 2022 outbreak |
gptkbp:death |
3 to 6 percent
|
gptkbp:diagnosis |
clinical evaluation
serological tests serological testing PCR test PCR testing |
gptkbp:diseases |
2022 global outbreak
|
gptkbp:endemic_to |
Central and West Africa
|
gptkbp:epidemiology |
endemic in certain regions
outbreaks reported globally |
gptkbp:first_reported_case |
gptkb:Democratic_Republic_of_the_Congo
|
gptkbp:geographic_distribution |
Central Africa
West Africa |
https://www.w3.org/2000/01/rdf-schema#label |
M-Pox
|
gptkbp:incubation_period |
7 to 14 days
up to 21 days |
gptkbp:is_recognized_as |
gptkb:1970
|
gptkbp:is_vulnerable_to |
gptkb:ACAM2000
gptkb:JYNNEOS |
gptkbp:prevention |
vaccination
avoiding contact with infected individuals |
gptkbp:propagation_method |
direct contact with infected lesions
|
gptkbp:public_awareness |
gptkb:educational_campaigns
community engagement healthcare provider training |
gptkbp:related_to |
gptkb:smallpox
|
gptkbp:research_focus |
treatment efficacy
vaccine development long-term effects treatment options public health strategies transmission dynamics |
gptkbp:risk_factor |
pregnant women
young children immunocompromised individuals travel to endemic areas close contact with infected animals contact with animals contact with infected humans |
gptkbp:scientific_classification |
public health emergency
|
gptkbp:symptoms |
fatigue
headache hydration fever pain relief sore throat rash secondary infections chills swollen lymph nodes skin lesions 2 to 4 weeks muscle aches conjunctivitis respiratory symptoms antipyretics |
gptkbp:transmission |
sexual contact
human-to-human contact contact with contaminated materials droplet transmission |
gptkbp:treatment |
gptkb:cidofovir
gptkb:vaccinia_immune_globulin supportive care antiviral medications tecovirimat |
gptkbp:variant |
Congo Basin clade
West African clade clade I clade II |
gptkbp:vector |
domestic animals
rodents primates |